Suprainguinal Fascia Iliaca Block vs. Adductor Canal Block for Analgesia After Total Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-100
SponsorBursa Yuksek Ihtisas Training and Research Hospital

About this trial

This study evaluates the analgesic efficacy and motor-sparing properties of ultrasound-guided Suprainguinal Fascia Iliaca Block (S-FIB) compared with Adductor Canal Block (ACB) in patients undergoing primary total knee arthroplasty (TKA). The main hypothesis is that ACB better preserves quadriceps muscle strength, allowing earlier functional mobilization, while providing comparable (non-inferior) analgesia to S-FIB.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA Physical Status I, II, or III

Scheduled for elective unilateral primary total knee arthroplasty

Able to understand and operate the PCA device

Written informed consent provided

Disqualifiers

Pre-existing lower-extremity neurological deficit or motor weakness (e.g., severe diabetic neuropathy)

Chronic opioid use (>30 mg oral morphine equivalents/day for >3 months)

Infection at the block site or systemic sepsis

Coagulopathy or bleeding diathesis

Trial design

Design model

Parallel

Treatments tested in this trial

  • PCA

    Drug

    All patients receive standardized spinal anesthesia and postoperative intravenous PCA tramadol within a standardized multimodal regimen.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: S-FIBActive comparator 1 intervention
Group B: ACBActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Pain Intensity (NRS)

Numerical Rating Scale (0-10) at rest and during active knee flexion (30°). Time Frame: Postoperative hours 2, 6, 12, 24, and 48.

Time frame
Postoperative hours 24 hour

Secondary outcomes

1

Quadriceps Muscle Strength

Active Straight Leg Raise (SLR) Angle Maximum hip flexion angle (degrees, 0-90°) achieved during an active straight leg raise in the supine position, measured with a digital clinometer/goniometer.

Time frame
Postoperative hours 6 and 12.
2

Cumulative Opioid Consumption

Total IV tramadol delivered via PCA (patient controlled analgesia).

Time frame
24 and 48 hours postoperatively.
3

Time to First Mobilization

Hours from end of surgery to first assisted/unassisted ambulation

Time frame
Up to 48 hours postoperatively.
4

Quality of Recovery (QoR-15)

Validated 15-item questionnaire (0-150; higher = better recovery).

Time frame
Baseline (preoperative) and 24 hours postoperatively.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: